Leila Risteli

12.3k citations

231 papers · 10.1k indexed · 1 hit paper · h-index 54

Impact in

Orthopedics and Sports Medicine top 0.2%
- Bone health and osteoporosis research
Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research

Papers in

Immunology and Allergy 39
- Cell Adhesion Molecules Research 39
Orthopedics and Sports Medicine 32
- Bone health and osteoporosis research 30

Co-authors: Juha Risteli S. Niemi Jukka Melkko Inkeri Elomaa Saila Kauppila Onni Niemelä Erik Fink Eriksen Frej Stenbäck
Journals: British Journal of Cancer (10 papers)Cancer (8 papers)Biochemical Journal (7 papers)Clinical Chemistry (7 papers)European Journal of Clinical Investigation (7 papers)
Partner nations: Finland United Kingdom Denmark

In The Last Decade

Leila Risteli

228 papers receiving 9.5k citations

Hit Papers

align trajectories log scale

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation 1993 · 549 citations

Peers

Countries citing papers authored by Leila Risteli

Since Specialization

Citations

This map shows the geographic impact of Leila Risteli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Risteli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Risteli more than expected).

Fields of papers citing papers by Leila Risteli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Risteli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Risteli. The network helps show where Leila Risteli may publish in the future.

Co-authors

The 25 scholars most cited alongside Leila Risteli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leila Risteli Line = papers co-authored together Leila Risteli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mannose Receptor-Mediated Regulation of Serum Glycoprotein Homeostasis Science ·Sena J. Lee, Stefan Evers, Daniel Roeder, Albert F. Parlow, Juha Risteli, Leila Risteli, Y. C. Lee, Ten Feizi, Hanno Langen, Michel C. Nussenzweig	2002	393
2	Type I collagen metabolites as tumor markers in patients with lung carcinoma Cancer ·Tetsu Kobayashi, Esteban C. Gabazza, Osamu Taguchi, Juha Risteli, Leila Risteli, Hiroyasu Kobayashi, Hiroki Yasui, Hisamichi Yuda, Takashi Sakai, Masanori Kaneda, Yukihiko Adachi	1999	32
3	The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study Annals of the Rheumatic Diseases ·S Aman, Juha Risteli, Reijo Luukkainen, Leila Risteli, Markku Kauppi, Pentti Nieminen, Markku Hakala	1999	14
4	Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma British Journal of Cancer ·Carl Blomqvist, Leila Risteli, Juha Risteli, Pekka Virkkunen, Seppo Sarna, Inkeri Elomaa	1996	54
5	Type I and type III collagen metabolites in adult osteosarcoma patients British Journal of Cancer ·Tom Wiklund, Carl Blomqvist, Leila Risteli, Juha Risteli, E Karaharju, Inkeri Elomaa	1996	6
6	Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut ·J Silvennoinen, Leila Risteli, Tuomo J. Karttunen, Juha Risteli	1996	52
7	Effects of low‐ and conventional‐dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women European Journal of Clinical Investigation ·Christopher Sharp, Sharon Evans, Leila Risteli, Juha Risteli, M. Worsfold, Margaret Davies	1996	30
8	Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma European Journal of Cancer ·Inkeri Elomaa, Leila Risteli, Markku Laakso, R Lahtinen, Pekka Virkkunen, Juha Risteli	1996	25
9	Elevated Serum ICTP Concentrations Reflect Poor Prognosis in Patients with Ovarian Carcinoma Annals of Medicine ·Markku Santala, Leila Risteli, Ulla Puistola, Juha Risteli, Antti Kauppila	1995	15
10	Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer British Journal of Cancer ·Timo Kylmälä, TLJ Tammela, Leila Risteli, Juha Risteli, M Kontturi, Inkeri Elomaa	1995	80
11	Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. The Journal of Experimental Medicine ·Jukka Melkko, Turid Hellevik, Leila Risteli, Juha Risteli, Bård Smedsrød	1994	120
12	A simple method for predicting bone fractures in PBC patients after liver transplantation Transplant International ·Krister Höckerstedt, Helena Isoniemi, Juha Risteli, Leila Risteli	1994	2
13	Altered collagen expression in human dentin: increased reactivity of type III and presence of type VI in dentinogenesis imperfecta, as revealed by immunoelectron microscopy. Journal of Histochemistry & Cytochemistry ·Janna Waltimo, Leila Risteli, Juha Risteli, P.-L. Lukinmaa	1994	16
14	Effect of gynecological operations on the serum concentration of the aminoterminal propeptide of type III procollagen Acta Obstetricia Et Gynecologica Scandinavica ·Candido Tomás, Ulla Puistola, Leila Risteli, Juha Risteli, Antti Kauppila	1993	1
15	Serum Procollagen Peptides and Collagen Type Vi for the Assessment of Activity and Degree of Hepatic Fibrosis in Schistosomiasis and Alcoholic Liver Disease Hepatology ·Manal Shahin, Detlef Schuppan, Rüdiger Waldherr, Juha Risteli, Leila Risteli, Eeva‐Riitta Savolainen, Christine Oesterling, H. M. Abdel Rahman, Abdul M. El Sahly, Samia M. Abdel Razek, Omar El Ruby, A Koch, Helmut K. Seitz	1992	66
16	Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP) British Journal of Haematology ·T. Taube, Kaarle Franssila, Leila Risteli, Juha Risteli And, Inkeri Elomaa	1992	13
17	Effect of intravenous feeding on wound healing in starvation: an experimental study on the rabbit. PubMed ·Haukipuro Ka, Harju Ej, Leila Risteli	1991	2
18	Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinoma Cancer ·Cazenave Tomás, Jorma Penttinen, Juha Risteli, Leila Risteli, J. Vuori, Antti Kauppila	1990	18
19	Immunoelectron microscopic localization of laminin, type IV collagen, and type III pN-collagen in reticular fibers of human lymph nodes. Journal of Histochemistry & Cytochemistry ·Tuomo J. Karttunen, Raija Sormunen, Leila Risteli, Juha Risteli, Helena Autio‐Harmainen	1989	33
20	Effect of the structural components of basement membranes on the attachment of teratocarcinoma-derived endodermal cells Experimental Cell Research ·Aarno Palotie, Leena Peltonen, Leila Risteli, Juha Risteli	1983	12

About Leila Risteli

Leila Risteli is a scholar working on Immunology and Allergy, Orthopedics and Sports Medicine, Cancer Research, Rheumatology and Oncology, having authored 231 papers that have together received 10.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (39 papers), Protease and Inhibitor Mechanisms (34 papers), Bone health and osteoporosis research (30 papers), Bone health and treatments (28 papers), Connective tissue disorders research (25 papers), Collagen: Extraction and Characterization (19 papers), Bone and Dental Protein Studies (17 papers) and Bone Metabolism and Diseases (15 papers). The work is most often cited by research in Orthopedics and Sports Medicine (2.0k citations), Immunology and Allergy (1.1k citations), Oncology (2.3k citations), Rheumatology (1.1k citations) and Cancer Research (1.0k citations). Leila Risteli has collaborated with scholars based in Finland, United Kingdom and Denmark. Frequent co-authors include Juha Risteli, S. Niemi, Jukka Melkko, Inkeri Elomaa, Saila Kauppila, Onni Niemelä, Erik Fink Eriksen, Frej Stenbäck, Antti Kauppila and Leif Mosekilde. Their work appears in journals such as British Journal of Cancer, Cancer, Biochemical Journal, Clinical Chemistry and European Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact